Wegovy Weight Loss Pill Now Available in UK - Here's What You Need to Know

New Delhi, India Jul 6, 2026 ALN: The once-a-day Wegovy weight loss pill is now available to buy privately from High Street and online pharmacies in the UK - but is not yet on the NHS.

It contains the same active ingredient - semaglutide - as the Wegovy weight loss injections but is still advised to be used alongside a healthy diet and increased physical activity. The introduction of this oral form of semaglutide represents a significant development in the realm of obesity treatment, providing an alternative to those who may be apprehensive about injections or find them inconvenient.

So, what do you need to know about this pill version of the skinny jab?

How do you take the pill?

There are several strict guidelines to help ensure the pill is absorbed effectively by the body. Here are the recommended steps:

• Take the pill on an empty stomach after not eating for at least eight hours.
• Wait at least 30 minutes before eating or drinking anything else or taking other tablets.
• Swallow the pill whole with a sip of plain water (up to 120ml) - it is important to avoid fizzy water, coffee, or tea.

For optimal results, it is recommended to take the pill at the same time every day, which can help establish a routine. If a dose is missed, the advice is to skip that day's dose and resume with the scheduled dose the following day, rather than doubling up.

Tablets vs Injection

Aside from the obvious difference in form, both treatments have been shown to be effective in clinical trials. They work through the same mechanism, targeting the GLP-1 receptors in the brain that regulate appetite. For individuals who are needle-averse, the tablet form may be more appealing. However, those who prefer a less frequent dosing schedule may find the once-weekly injection more convenient. It is also noteworthy that the injection must be stored in the refrigerator, which may add an additional layer of complexity for some users.

Who can get the pill and where can you buy it?

The pill is available to individuals with a Body Mass Index (BMI) of 30 and above, which is generally classified as obese. It is also available for those with a BMI between 27 and 30 (considered overweight) if they have specific weight-related health conditions, such as type 2 diabetes or high blood pressure. This eligibility criteria aligns closely with that of the injectable version.

To obtain the pill, individuals must undergo a consultation, either online or in person, to determine if the medication is appropriate for them. Various online and high street pharmacies have indicated that they will soon have stock available for purchase. Prospective users are advised to for waiting lists or mailing lists to receive updates on availability.

It is crucial to seek out credible and reputable sources when purchasing medication to avoid counterfeit products. The rise of online pharmacies has made it easier for individuals to access medications, but it has also increased the risk of encountering fraudulent products.

What are the side effects?

The semaglutide in both the oral and injectable forms mimics the actions of the hormone GLP-1 (glucagon-like peptide-1), which is released from the intestine after eating. This hormone plays a key role in regulating appetite and energy balance. By acting on receptors in the brain, semaglutide helps individuals feel fuller, reduces hunger, and decreases cravings for food.

Common side effects associated with both forms of semaglutide include gastrointestinal issues such as nausea, vomiting, constipation, and diarrhea. With the injectable version, users may also experience localized reactions at the injection site, such as redness, itching, or mild swelling. Other reported side effects include stomach pain, headaches, and feelings of tiredness. While these side effects are often mild and transient, more serious complications can occur in rare cases, including low blood sugar, pancreatitis, or severe allergic reactions. It is important for individuals to review the patient information leaflet for comprehensive details on side effects and contraindications.

Individuals under 18, pregnant or breastfeeding women, and those with specific medical conditions or medications should consult a healthcare professional before starting this medication.

What dose do you start on?

The recommended starting dose for the Wegovy pill is a 1.5mg tablet taken once daily for the first month. After this initial period, and following consultation with a healthcare provider, the dosage may be gradually increased each month until reaching the maximum recommended dose of 25mg once daily. It is important to note that, similar to the injections, it may take several months to achieve the full benefits of the medication. Additionally, there is a possibility that weight may be regained after discontinuation of the treatment, highlighting the importance of lifestyle changes alongside medication.

Patients currently using a 2.4mg semaglutide injection may switch to the daily semaglutide 25mg tablets under medical supervision. As with any medication transition, it is crucial to consult with a healthcare professional to determine the most appropriate treatment plan tailored to the individual's needs.

How much does it cost and will it be cheaper than the injection?

The cost of the Wegovy pill can vary depending on the pharmacy and the specific dose prescribed. Some pharmacies are offering limited-time introductory promotions, which may make the initial costs more affordable. For example, the lowest dose (1.5mg) has been priced at around £99 for a month's supply, while the highest dose (25mg) may cost approximately £199 for a 30-day supply. In comparison, when Wegovy was launched in the United States, the manufacturer set the price for the 1.5mg dose at $149 (approximately £110) per month.

There is hope that the pill may ultimately be more cost-effective than the injection in the long term, although this remains uncertain at this stage. Currently, some pharmacies are charging similar prices for both forms of treatment, making it essential for consumers to shop around for the best options.

When will it be available on the NHS?

Earlier this month, the Wegovy pill became the first oral medication of its kind to receive clearance from the Medicines and Healthcare products Regulatory Agency (MHRA). However, it is still not available on the NHS. The next step involves the National Institute for Health and Care Excellence (NICE) evaluating the medication to determine its cost-effectiveness and overall benefit to patients. NICE will review trial data provided by the manufacturer, along with other relevant information, to make an informed recommendation.

Adam Burt, the head of obesity at pharmaceutical company Novo Nordisk, emphasized the need for the medication to demonstrate cost-effectiveness for the NHS and taxpayers. He indicated that the review process typically takes between nine to twelve months, meaning that patients may have to wait some time before the medication is accessible through the public health service.

In summary, while the Wegovy weight loss pill offers a promising new option for individuals struggling with obesity, it is essential to approach its use with caution and under the guidance of healthcare professionals. As the landscape of obesity treatment continues to evolve, the implications of this new medication could have lasting effects on public health and individual treatment plans.